BIO KEY International INC Stock: price and management transactions · United States · SEC (Form 4)

About BIO KEY International INC

BIO-key International Inc. (ticker BKYI) is a U.S.-listed company trading on the NASDAQ market in the United States. It operates in the cybersecurity and digital identity space, with a focus on Identity and Access Management (IAM) and biometric authentication. The company develops technologies designed to verify user identity and secure access to applications, data, and physical environments. Its customer base is oriented toward enterprise, government, education, and other security-sensitive organizations, where strong authentication and frictionless access are increasingly important. BIO-key’s product set includes fingerprint-based technologies, complementary biometric solutions, and enterprise software used to manage identity and authentication workflows. ([bio-key.com](https://www.bio-key.com/company/?utm_source=openai)) Founded in 1993, the company originally operated under the name SAC Technologies before changing its name to BIO-key International in 2002. That history gives BIO-key a long operating record in biometrics, a niche that has evolved from specialized hardware and identification systems toward software-led IAM and identity verification. The company is headquartered in Holmdel, New Jersey, which places it within the U.S. East Coast technology and security ecosystem. BIO-key positions itself as a specialist provider rather than a broad cybersecurity platform, and that specialization is central to its investment story. ([bio-key.com](https://www.bio-key.com/company/?utm_source=openai)) From a competitive standpoint, BIO-key is a small-cap player competing against much larger IAM, cybersecurity, and authentication vendors. Its differentiation lies in biometrics-centric identity solutions, particularly fingerprint-based authentication and identity-bound access workflows. The company emphasizes a security-first approach that can reduce reliance on passwords and improve both user convenience and enterprise control. BIO-key also highlights customer relationships across financial services, healthcare, education, manufacturing, communications, transportation, and government, which suggests a diversified vertical footprint even though the company remains financially small. ([bio-key.com](https://www.bio-key.com/company/?utm_source=openai)) BIO-key’s core offering is best understood as a combination of IAM software and biometric authentication technology. Its solutions are built for organizations that need stronger identity assurance, whether for employee login, customer authentication, privileged access, or regulated workflows. The company markets fingerprint identification biometric technology and enterprise-ready identity access management solutions, and it also integrates biometric devices and software into its platform. BIO-key’s participation in the FIDO Alliance and the International Biometrics Identity Association supports its credibility as a standards-aware vendor in the authentication market. ([bio-key.com](https://www.bio-key.com/company/?utm_source=openai)) Recent company developments have centered on product refreshes and financial stabilization. In 2025, BIO-key announced its EcoID III USB fingerprint scanner, which carries FBI FAP 20 certification, a useful marker for government and enterprise credibility in biometric hardware. The company also reported quarterly results in 2025 and said it had improved its balance sheet, while investor materials published in early 2026 pointed to a modest market capitalization and revenue base, underscoring that BKYI remains a micro-cap name with meaningful execution risk. As a U.S. NASDAQ-listed issuer, BIO-key is also followed for SEC Form 4 insider transaction activity, which can attract attention from market participants watching management behavior in small-cap stocks. ([bio-key.com](https://www.bio-key.com/wp-content/uploads/2025/11/Digital-Identity-and-Biometric-Access-Management-Provider-BIO-key-Reports-Q3-Results-Highlights-Enhanced-Post-Quarter-Balance-Sheet-to-Support-2026-Growth-Goals-Holds-Investor-Call-10am-ET-Today.pdf?utm_source=openai))